If you have been reading about Cardarine and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Human trials of GW501516 were small and short in duration. They examined lipid levels, glucose handling, and other metabolic markers, but the programs were halted after the animal cancer findings. No approved therapeutic product exists, and published human data are insufficient for establishing long-term safety. Reports of use for athletic performance come mainly from non-clinical settings and cannot be verified through controlled trials. Independent testing of products sold as cardarine has found inconsistent purity and labeling.
Laboratory studies indicate that GW501516 activates PPARδ, a nuclear receptor involved in fatty acid oxidation and energy metabolism. In rodent experiments, treated animals often showed increased endurance and reduced fat mass. These effects were observed under controlled conditions and do not establish safe or effective use in humans. The exact dose-response relationship in humans remains poorly characterized. Species differences in metabolism can affect how results translate across animals and people.
Safety concerns emerged from long-term animal studies. In rodents given the compound for extended periods, researchers found an increased incidence of certain cancers, including liver and bladder tumors. These findings contributed to the discontinuation of clinical development. Whether similar risks apply to short-term or low-level exposure in humans is not established, and controlled human safety data are limited. The relevance of high-dose rodent carcinogenicity findings to human use remains a subject of debate.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
| Property | Value | Notes |
|---|---|---|
| Primary target | PPARδ (NR1C2) | Nuclear receptor involved in lipid metabolism |
| Preclinical effect | Increased fatty acid oxidation | Observed in rodent studies |
| Key safety signal | Tumors in rodents after long-term exposure | Contributed to halted clinical development |
| Human trial status | No approved product; development stopped | Limited short-term metabolic data |
| Sport regulatory status | Prohibited at all times | WADA hormone and metabolic modulators class |
The compound is typically described as a laboratory compound rather than a therapeutic product. Published reports have explored its role in lipid disorders, insulin sensitivity, and exercise metabolism, yet no major drug regulator has approved it for medical use. Commercial samples sold under the cardarine name may vary in purity and identity. Analytical confirmation is therefore necessary when the material is discussed in scientific or regulatory contexts. Its classification as a prohibited substance in sport further shapes how it is studied and reported.
Cardarine is a common name for GW501516, a synthetic compound studied for its effects on lipid and glucose metabolism. It functions as an agonist at peroxisome proliferator-activated receptor delta, or PPARδ, a nuclear receptor that influences gene expression. The molecule is not a steroid, nor is it a selective androgen receptor modulator. It is also known in research and sports literature as GW-501516 and endurobol. Early laboratory work examined its metabolic activity in cell cultures and animal models.
Activation of PPARδ changes transcription of genes involved in fatty acid transport, mitochondrial function, and skeletal muscle fuel preference. In rodent studies, pharmacological PPARδ activation was associated with increased endurance and altered body composition. These findings generated interest in performance enhancement, but species differences and study designs limit direct extrapolation to humans. Small human trials were conducted in the 2000s and later discontinued. The extent to which cardarine produces similar metabolic or performance effects in people remains an open question.
Cardarine is frequently described as a fat-burning or endurance-enhancing supplement, but these claims exceed the available evidence. The compound is not a hormone, steroid, or selective androgen receptor modulator. Research articles discuss it as a tool compound for studying PPARδ biology, while anti-doping literature focuses on its abuse and detection. Quality of unapproved products is uncertain, and independent analyses have found impurities or incorrect labeling. Open questions include whether human cancer risk resembles that seen in rodents and how often non-athletes use the substance.
Cardarine has no approved therapeutic indication and is not marketed as a medicine. The World Anti-Doping Agency lists GW501516 as a prohibited substance at all times, covering both in-competition and out-of-competition periods. National laws vary: some countries treat it as an unapproved drug subject to import controls, while others have specific restrictions on sale for human consumption. It is often sold as a research chemical, a label that does not imply safety or legality. Enforcement actions have targeted online vendors and shipments.
Anti-doping laboratories identify GW501516 and related metabolites using liquid chromatography coupled with tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be analyzed. The method targets the parent compound and phase I and phase II metabolites, which extend the detection window. Because the substance is prohibited at all times, athletes can be tested outside competition. Detection limits and windows depend on the assay, sample type, and individual metabolism.
The 52nd G7 Summit was an annual summit of the G7 held from 15 to 17 June 2026 in Évian-les-Bains, Haute-Savoie, France. Évian-les-Bains previously hosted the 29th G8 summit in 2003. The 2026 summit therefore makes Évian the first French town to host a G7 or G8 leaders' summit twice. At the summit, leaders issued joint statements on Ukraine, the Middle East, critical minerals and global economic imbalances, among other issues.
== Products == Renovo does not currently have any marketed products. Its development pipeline currently includes one drug in phase III clinical development, two in phase II clinical development, and numerous pre-clinical candidates.
=== Inhibition === NADPH oxidase can be inhibited by apocynin, nitric oxide (NO), and diphenylene iodonium. Apocynin acts by preventing the assembly of the NADPH oxidase subunits. Apocynin decreases influenza-induced lung inflammation in mice in vivo and so may have clinical benefits in the treatment of influenza. Inhibition of NADPH oxidase by NO blocks the source of oxidative stress in the vasculature. NO donor drugs (nitrovasodilators) have therefore been used for more than a century to treat coronary artery disease, hypertension, and heart failure by preventing excess superoxide from deteriorating healthy vascular cells. More advanced NADPH oxidase inhibitors include GKT-831 (Formerly GKT137831), a dual Inhibitor of isoforms NOX4 and NOX1 which was patented in 2007. The compound was initially developed for Idiopathic pulmonary fibrosis and obtained orphan drug designation by the FDA and EMA at end of 2010.
This tag is used for protein purification of peptides, fragments of mAbs, recombinant proteins and its fragments. It can be used in research labs and it is intended for large-scale purification during downstream manufacturing process as well. The iCapTag™-target protein complex can be expressed in a wide range of expression hosts (e.g. CHO and E.coli cells) polyglutamate tag, a peptide binding efficiently to anion-exchange resin such as Mono-Q (EEEEEE) polyarginine tag, a peptide binding efficiently to cation-exchange resin (from 5 to 9 consecutive R) E-tag, a peptide recognized by an antibody (GAPVPYPDPLEPR) FLAG-tag, a peptide recognized by an antibody (DYKDDDDK) HA-tag, a peptide from hemagglutinin recognized by an antibody (YPYDVPDYA) His-tag, 5-10 histidines bound by a nickel or cobalt chelate (HHHHHH) Gly-His-tags are N-terminal His-Tag variants (e.g. GHHHH, or GHHHHHH, or GSSHHHHHH) that still bind to immobilised metal cations but can also be activated via azidogluconoylation to enable click-chemistry applications Myc-tag, a peptide derived from c-myc recognized by an antibody (EQKLISEEDL) NE-tag, an 18-amino-acid synthetic peptide (TKENPRSNQEESYDDNES) recognized by a monoclonal IgG1 antibody, which is useful in a wide spectrum of applications including Western blotting, ELISA, flow cytometry, immunocytochemistry, immunoprecipitation, and affinity purification of recombinant proteins Rho1D4-tag, refers to the last 9 amino acids of the intracellular C-terminus of bovine rhodopsin (TETSQVAPA).
A direct relativistic effect is that as the atomic numbers of elements increase, the innermost electrons begin to revolve faster around the nucleus as a result of an increase of electromagnetic attraction between an electron and a nucleus. Similar effects have been found for the outermost s orbitals (and p1/2 ones, though in dubnium they are not occupied): for example, the 7s orbital contracts by 25% in size and is stabilized by 2.6 eV. A more indirect effect is that the contracted s and p1/2 orbitals shield the charge of the nucleus more effectively, leaving less for the outer d and f electrons, which therefore move in larger orbitals. Dubnium is greatly affected by this: unlike the previous group 5 members, its 7s electrons are slightly more difficult to extract than its 6d electrons.
Sources: en.wikipedia.org
== Legal basis == As early as 1905, the Frenchman Viktor Hennecart called for special legislation to regulate the use of X-rays. In England, Sidney Russ (1879-1963) suggested to the British Roentgen Society in 1915 that it should develop its own set of safety standards, which it did in July 1921 with the formation of the British X-Ray and Radium Protection Committee. In the United States, the American X-Ray Society developed its own guidelines in 1922. In the German Reich, a special committee of the German X-Ray Society under Franz Maximilian Groedel (1881-1951), Hans Liniger (1863-1933) and Heinz Lossen (1893-1967) formulated the first guidelines after the First World War. In 1953, the employers' liability insurance associations issued the accident prevention regulation "Use of X-rays in medical facilities" based on the legal basis in § 848a of the Reich Insurance Code (RVG). In the GDR, the Occupational Safety and Health Regulation (ASAO) 950 was in effect from 1954 to 1971. It was replaced by ASAO 980 on April 1, 1971.
CH2=CH(NH2)CO2H + H2O → CH3−C(O)CO2H + NH3 N-Acylated derivatives of dehydroalanine, such as are found peptides and related compounds, are stable. One such example is methyl 2-acetamidoacrylate. As a residue in a peptide, dehydroalanine is generated by a post translational modification. The required precursors are serine or cysteine residues, which undergo enzyme-mediated loss of water and hydrogen sulfide, respectively. Most amino acid residues are unreactive toward nucleophiles, but those containing dehydroalanine or some other dehydroamino acids are exceptions. These residues are electrophilic due to the α,β-unsaturated carbonyl, and can, for example, alkylate other amino acids. This activity has made DHA useful synthetically to prepare lanthionine.
==== United States ==== In the United States, codeine is regulated by the Controlled Substances Act. Federal law dictates that codeine be a Schedule II controlled substance when used in products for pain relief that contain codeine alone or more than 80 mg per dosage unit. Codeine without aspirin or acetaminophen (Tylenol) is very rarely available or prescribed to discourage abuse. Tablets of codeine in combination with aspirin or acetaminophen (paracetamol) and intended for pain relief are listed as Schedule III. Cough syrups are classed as Schedule III, IV, or V, depending on formulation. For example, the acetaminophen/codeine antitussive liquid is a Schedule IV controlled substance. Some states have chosen to reclassify codeine preparations at a more restrictive schedule to lower the instances of its abuse. Minnesota, for instance, has chosen to reclassify Schedule V some codeine preparations (e.g. Cheratussin) as a Schedule III controlled substance.
== Therapeutic potential == Like other opioids, it has potential in pain management; however, by being selective for the delta receptor, multiple undesirable side effects of traditional opioids are not present, such as respiratory depression, sedation, and euphoria. ADL-5859 was also found to be orally active, which makes it easier to administer. Multiple tests have shown its efficacy as an analgesic. It also did not seem to be a convulsant, unlike some other delta agonist opioids.
The Pacinian corpuscle (also lamellar corpuscle, or Vater–Pacini corpuscle) is a low-threshold mechanoreceptor, responsive to deep pressure, stretch, tickle and vibration, found in the skin and other internal organs. In the skin it is one of the four main types of cutaneous receptors. The corpuscles are present in skin notably on both surfaces of the hands and feet, arms, and neck. Pacinian corpuscles are also found on bone periosteum, joint capsules, the pancreas and other internal organs, the breast, genitals, and lymph nodes. Pacinian corpuscles are rapidly adapting mechanoreceptors. As phasic receptors they respond quickly but briefly to a stimulus with the response diminishing even when the stimulus is maintained. They primarily respond to vibration, and deep pressure. They are especially sensitive to high-frequency vibrations. Groups of corpuscles sense pressure changes (such as on grasping or releasing an object). They are additionally crucially involved in proprioception. The vibrational role may be used for detecting surface texture, such as rough and smooth.
Sources: en.wikipedia.org
=== Radiographs === A few techniques are used to confirm the diagnosis in TCS. An orthopantomogram (OPG) is a panoramic dental X-ray of the upper and lower jaw. It shows a two-dimensional image from ear to ear. Particularly, OPG facilitates an accurate postoperative follow-up and monitoring of bone growth under a mono- or double-distractor treatment. Thereby, some TCS features could be seen on OPG, but better techniques are used to include the whole spectrum of TCS abnormalities instead of showing only the jaw abnormalities. Another method of radiographic evaluation is taking an X-ray image of the whole head. The lateral cephalometric radiograph in TCS shows hypoplasia of the facial bones, like the malar bone, mandible, and the mastoid. Finally, occipitomental radiographs are used to detect hypoplasia or discontinuity of the zygomatic arch.
The puff adder (Bitis arietans) is responsible for more fatalities than any other African snake. This is due to a combination of factors, including its wide distribution, common occurrence, large size, potent venom that is produced in large amounts, long fangs, their habit of basking by footpaths and sitting quietly when approached. The venom has cytotoxic effects and is one of the most toxic of any vipers based on LD50 studies. The LD50 values in mice vary: 0.4–2.0 mg/kg IV, 0.9–3.7 mg/kg IP, 4.4–7.7 mg/kg SC. Mallow et al. (2003) gives a LD50 range of 1.0–7.75 mg/kg SC. Venom yield is typically between 100–350 mg, with a maximum of 750 mg. Brown (1973) mentions a venom yield of 180–750 mg. About 100 mg is thought to be enough to kill a healthy adult human male, with death occurring after 25 hours. In humans, bites from this species can produce severe local and systemic symptoms. Based on the degree and type of local effect, bites can be divided into two symptomatic categories: those with little or no surface extravasation, and those with hemorrhages evident as ecchymosis, bleeding and swelling. In both cases there is severe pain and tenderness, but in the latter there is widespread superficial or deep necrosis and compartment syndrome. Serious bites cause limbs to become immovably flexed as a result of significant hemorrhage or coagulation in the affected muscles. Residual induration, however, is rare and usually these areas completely resolve. The fatality rate depends on the severity of the bites and some other factors.
The Parliament of Malaysia consists of the Yang di-Pertuan Agong (King) and two houses, the Dewan Rakyat (the House of Representatives) and Dewan Negara (the Senate). The term "members of Parliament" only refers to members of the Dewan Rakyat. In Malay, a member of Parliament is called Ahli Parlimen, or less formally wakil rakyat (people's representative). Members of Parliament are elected from population-based single-seat constituencies using first-past-the-post voting. The prime minister must be a member of Parliament. Members of Parliament are styled Yang Berhormat ("Honourable") with the initials Y.B. appended prenominally. A prince who is a member of Parliament is styled Yang Berhormat Mulia. The prime minister, deputy prime minister and Tuns who are members of Parliament are styled Yang Amat Berhormat ("Most Honourable"), abbreviated Y.A.B.
=== Nitrogen relationships === Xanthoria parietina is highly adaptable to nitrogen-rich environments, with thalli containing between 11 and 43 milligrams per gram of nitrogen (dry weight), a broader range than most other green algal lichens. The species maintains metabolic balance by shifting resource allocation between its fungal and algal partners, directing more resources to its photobiont under high nitrogen conditions. Unlike nitrogen-sensitive species, X. parietina sustains consistent growth patterns regardless of nitrogen concentration, allowing it to thrive in agricultural areas and urban centers. his adaptation to high nitrogen environments explains its frequent association with eutrophication and its common presence near farmland and livestock facilities. Transplant experiments near a pig farm in Denmark further demonstrated its nitrogen accumulation ability. Lichen thalli exposed to high ammonia levels rapidly increased their nitrogen content, reaching approximately 2.1% within a month, whereas samples positioned 300 meters away maintained lower levels (around 1.6%). In situ samples collected along a transect exhibited a strong linear correlation between thallus nitrogen content and the logarithm of ambient ammonia concentrations. Additional research suggests that X. parietina's nitrogen tolerance may be linked to osmotic adaptations rather than a direct nitrogen preference. It is primarily halotolerant and xerophytic, with cell osmotic values significantly higher than those of non-nitrophytic species.
Neurotransmitters are generally stored in synaptic vesicles, clustered close to the cell membrane at the axon terminal of the presynaptic neuron. However, some neurotransmitters, like the metabolic gases carbon monoxide and nitric oxide, are synthesized and released immediately following an action potential without ever being stored in vesicles.
Sources: en.wikipedia.org
Rodent studies reported increased endurance and fat oxidation after GW501516 exposure. Long-term studies also found higher rates of some tumors, which led to halted development.
Small short-term human trials examined metabolic markers such as lipids and glucose. The trials did not continue after rodent cancer findings, so long-term human safety is unknown.
Controlled human trials have not established a performance benefit. Anecdotal reports exist, but they are not reliable evidence.
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.